Curie.Bio
Biotech firm accelerating discovery of next generation human medicines
Curie.Bio is a new model for venture capital in biotech focused on helping founders launch serious therapeutics companies. The company is a unique combination of two businesses: we act as both your drug discovery copilot & seed investor.
Curie.Bio does this by giving founders access to a team of the world’s best drug hunters and drug makers, seed capital, and best-of-breed services - everything a founder needs to get from concept to a compelling quality dataset that enables an awesome Series A financing.
Visit website: https://curie.bio/
Details last updated 14-Nov-2023
Curie.Bio News
Forward therapeutics secures $50m to develop next-gen small molecule immune therapies
Longevity Technology - 09-Nov-2023
Company's pipeline targets inflammation, promote healing, and restore quality of life
Read more...